With many Americans working at home and engaging in online learning, screen time has been rising and has subsequently been increasing exposure of the eyes to harmful blue light. As a result, Americans are experiencing more digital eye strain, which can lead to irritated and dry eyes.
When the Centers for Disease Control expanded its potential COVID-19 symptoms, pink eye was one possible indication of the virus. With red eye and pink eye easily confused, some consumers stocked up on allergy eye care to avoid mistaken symptoms.
Alcon Laboratories announced the release of Systane Hydration Preservative-Free in March 2020. Although the official launch was before the height of the COVID-19 pandemic in the US, Systane Hydration PF recognises the growing demand for eye lubricants in order to assist with irritations related to digital eye strain.
Prior to the increasing screen time caused by working at home and virtual learning in the wake of the COVID-19 pandemic, consumers were already spending more time on electronic devices as improvements to digital infrastructure were providing opportunities for Americans to incorporate more screen time into their lives. With the sudden disruption of COVID-19, mobile services such as telehealth and e-commerce have improved significantly and, in some ways, transformed Americans’ reliance on screens.
Following its split from Novartis AG in 2019, Alcon Laboratories secured the rights for the Rx-to-OTC switch of Pataday. In March 2020, the Pataday OTC line-up included once daily and twice daily formats and, in July 2020, Alcon once again received FDA approval for the OTC sale of Pataday Once Daily Relief Extra Strength.
With the Federal Trade Commission’s approval in May 2020, AbbVie Inc moved forward with its acquisition of Allergan Inc. Traditionally operating in the pharmaceutical space, this moved AbbVie into OTC eye care with the Refresh brands.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Eye Care industry in USA with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Eye Care industry in USA, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Eye Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page